{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:02:08Z","timestamp":1792116128010,"version":"4.4.0"},"reference-count":265,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009730","name":"Stand Up To Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["-6177"],"award-info":[{"award-number":["-6177"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016037","name":"Fondation Gustave Roussy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101095604"],"award-info":[{"award-number":["101095604"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825410"],"award-info":[{"award-number":["825410"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007322","name":"Fox Chase Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032616","name":"Starr Cancer Consortium","doi-asserted-by":"publisher","award":["#I16-0064"],"award-info":[{"award-number":["#I16-0064"]}],"id":[{"id":"10.13039\/100032616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101052444"],"award-info":[{"award-number":["101052444"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2021-ADG"],"award-info":[{"award-number":["ERC-2021-ADG"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020424","name":"Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016784","name":"Equipex","doi-asserted-by":"publisher","award":["ANR-22-CE14-0066"],"award-info":[{"award-number":["ANR-22-CE14-0066"]}],"id":[{"id":"10.13039\/100016784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016784","name":"Equipex","doi-asserted-by":"publisher","award":["ANR-23-R4HC-0006 Ener-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 Ener-LIGHT"]}],"id":[{"id":"10.13039\/100016784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016784","name":"Equipex","doi-asserted-by":"publisher","award":["ANR-23-CE44-0030"],"award-info":[{"award-number":["ANR-23-CE44-0030"]}],"id":[{"id":"10.13039\/100016784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016784","name":"Equipex","doi-asserted-by":"publisher","award":["ANR-23-RHUS-0010 LUCA-pi"],"award-info":[{"award-number":["ANR-23-RHUS-0010 LUCA-pi"]}],"id":[{"id":"10.13039\/100016784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016784","name":"Equipex","doi-asserted-by":"publisher","award":["RHU ANR-21-RHUS-0017"],"award-info":[{"award-number":["RHU ANR-21-RHUS-0017"]}],"id":[{"id":"10.13039\/100016784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017320","name":"Luke Heller Tec Pr2 Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004795","name":"Institut Universitaire de France","doi-asserted-by":"publisher","award":["18713"],"award-info":[{"award-number":["18713"]}],"id":[{"id":"10.13039\/501100004795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015545","name":"Seerave Foundation","doi-asserted-by":"publisher","award":["18006"],"award-info":[{"award-number":["18006"]}],"id":[{"id":"10.13039\/100015545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ccell.2025.12.005","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T15:56:08Z","timestamp":1767196568000},"page":"281-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cancer cell death: Cell-autonomous and immunogenic dimensions"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-8500","authenticated-orcid":false,"given":"Lorenzo","family":"Galluzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daolin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.12.005_bib1","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A history of cancer chemotherapy","volume":"68","author":"DeVita","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.005_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.6093263","article-title":"Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation","volume":"226","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.12.005_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells","volume":"335","author":"Vaux","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/excr.1993.1176","article-title":"Ca2+ and endonuclease activation in radiation-induced lymphoid cell death","volume":"207","author":"Zhivotovsky","year":"1993","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ccell.2025.12.005_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood.V81.1.151.151","article-title":"Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line","volume":"81","author":"Miyashita","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.005_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis","volume":"2","author":"Igney","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","article-title":"The therapeutic potential of targeting regulated non-apoptotic cell death","volume":"22","author":"Hadian","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib19","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib20","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1182\/blood-2002-05-1389","article-title":"Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells","volume":"100","author":"Feng","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.005_bib21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc1613","article-title":"Immunotherapy and chemotherapy--a practical partnership","volume":"5","author":"Lake","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12964-021-00799-8","article-title":"Regulated cell death: discovery, features and implications for neurodegenerative diseases","volume":"19","author":"Cui","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ccell.2025.12.005_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2025.12.005_bib25","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ccell.2025.12.005_bib26","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","article-title":"Anoikis","volume":"12","author":"Gilmore","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2025.12.005_bib27","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/cells14141072","article-title":"Mechanistic Insights into Autophagy-Dependent Cell Death (ADCD): A Novel Avenue for Cancer Therapy","volume":"14","author":"Rahman","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ccell.2025.12.005_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.devcel.2016.04.018","article-title":"The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis","volume":"37","author":"Goodall","year":"2016","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib29","doi-asserted-by":"crossref","first-page":"20364","DOI":"10.1073\/pnas.1319661110","article-title":"Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.12.005_bib30","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3390\/cells13242095","article-title":"Methuosis, Alkaliptosis, and Oxeiptosis and Their Significance in Anticancer Therapy","volume":"13","author":"Bartoszewska","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ccell.2025.12.005_bib31","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2017.12.004","article-title":"JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice","volume":"154","author":"Song","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccell.2025.12.005_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12943-025-02445-0","article-title":"Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis","volume":"24","author":"Jing","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","article-title":"Mitochondrial metabolism promotes adaptation to proteotoxic stress","volume":"15","author":"Tsvetkov","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41568-018-0073-9","article-title":"Cell-in-cell phenomena in cancer","volume":"18","author":"Fais","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.cell.2007.10.040","article-title":"A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion","volume":"131","author":"Overholtzer","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","article-title":"Apoptosis in Cancer Biology and Therapy","volume":"20","author":"Moyer","year":"2025","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ccell.2025.12.005_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41568-025-00879-8","article-title":"Exploiting metabolic cell death for cancer therapy","volume":"26","author":"Mao","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib39","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib40","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41580-025-00873-w","article-title":"Lysosomal membrane homeostasis and its importance in physiology and disease","volume":"27","author":"Radulovic","year":"2026","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1084\/jem.20021952","article-title":"Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion","volume":"197","author":"Boya","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib43","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajpath.2014.02.028","article-title":"Methuosis: nonapoptotic cell death associated with vacuolization of macropinosome and endosome compartments","volume":"184","author":"Maltese","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2025.12.005_bib44","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1158\/1541-7786.MCR-07-2036","article-title":"Active ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis","volume":"6","author":"Overmeyer","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.005_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4161\/auto.3924","article-title":"Mitoptosis: different pathways for mitochondrial execution","volume":"3","author":"Tinari","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.ccell.2025.12.005_bib46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/152165400410209","article-title":"Mitochondria in the programmed death phenomena; a principle of biology: \u201cit is better to die than to be wrong\u201d","volume":"49","author":"Skulachev","year":"2000","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ccell.2025.12.005_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrm3115","article-title":"Mitotic catastrophe: a mechanism for avoiding genomic instability","volume":"12","author":"Vitale","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-021-00433-y","article-title":"Molecular mechanisms and consequences of mitochondrial permeability transition","volume":"23","author":"Bonora","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular Mechanisms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib52","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.12.005_bib53","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s10495-025-02087-z","article-title":"Role of oxeiptosis in disease mechanisms and therapeutic opportunities","volume":"30","author":"Bhuvaneshwari","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.ccell.2025.12.005_bib54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","article-title":"Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway","volume":"19","author":"Holze","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/1568026013394741","article-title":"Oxytosis: A novel form of programmed cell death","volume":"1","author":"Tan","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ccell.2025.12.005_bib56","article-title":"Paraptosis: a unique cell death mode for targeting cancer","volume":"14","author":"Hanson","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ccell.2025.12.005_bib57","doi-asserted-by":"crossref","first-page":"14376","DOI":"10.1073\/pnas.97.26.14376","article-title":"An alternative, nonapoptotic form of programmed cell death","volume":"97","author":"Sperandio","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.12.005_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116174","article-title":"Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke","volume":"228","author":"Yang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ccell.2025.12.005_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1126\/science.1072221","article-title":"Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor","volume":"297","author":"Yu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.12.005_bib60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molmed.2023.10.001","article-title":"Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes","volume":"30","author":"Pandeya","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib61","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191644","article-title":"Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease","volume":"217","author":"Malireddi","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm3999","article-title":"Live to die another way: modes of programmed cell death and the signals emanating from dying cells","volume":"16","author":"Fuchs","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib63","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","article-title":"Mechanistic insights into gasdermin-mediated pyroptosis","volume":"26","author":"Bai","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2958.2000.02103.x","article-title":"Salmonella induces macrophage death by caspase-1-dependent necrosis","volume":"38","author":"Brennan","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ccell.2025.12.005_bib65","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00018-016-2209-y","article-title":"Regulated cell death and adaptive stress responses","volume":"73","author":"Galluzzi","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ccell.2025.12.005_bib66","article-title":"Unravelling oncosis: morphological and molecular insights into a unique cell death pathway","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib67","first-page":"3","article-title":"Apoptosis, oncosis, and necrosis. An overview of cell death","volume":"146","author":"Majno","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2025.12.005_bib68","doi-asserted-by":"crossref","first-page":"880","DOI":"10.34133\/research.0880","article-title":"Triaptosis and Cancer: Next Hope?","volume":"8","author":"Li","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.ccell.2025.12.005_bib69","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","article-title":"Caspases in Cell Death, Inflammation, and Pyroptosis","volume":"38","author":"Kesavardhana","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib70","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41580-025-00869-6","article-title":"Regulation of inflammatory processes by caspases","volume":"26","author":"Beltr\u00e1n-Visiedo","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","article-title":"Mechanisms of BCL-2 family proteins in mitochondrial apoptosis","volume":"24","author":"Czabotar","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib73","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036384","article-title":"Death Receptors and Their Ligands in Inflammatory Disease and Cancer","volume":"12","author":"Annibaldi","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib74","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114495","article-title":"Dependence receptors: new targets for cancer therapy","volume":"13","author":"Brisset","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib75","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41580-022-00564-w","article-title":"Pore-forming proteins as drivers of membrane permeabilization in cell death pathways","volume":"24","author":"Vandenabeele","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib76","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2017.03.020","article-title":"ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences","volume":"169","author":"Gong","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets","volume":"23","author":"Vande Walle","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib78","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41577-025-01142-9","article-title":"New insights into the noncanonical inflammasome point to caspase-4 as a druggable target","volume":"25","author":"Elkayam","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib79","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Zheng","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ccell.2025.12.005_bib80","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","article-title":"A guideline on the molecular ecosystem regulating ferroptosis","volume":"26","author":"Dai","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib81","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib82","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ccell.2025.12.005_bib84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-immunol-112019-072301","article-title":"The Antisocial Network: Cross Talk Between Cell Death Programs in Host Defense","volume":"39","author":"Snyder","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib85","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib86","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.cmet.2025.03.014","article-title":"Cytosolic cytochrome c represses ferroptosis","volume":"37","author":"Song","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.ccell.2025.12.005_bib87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib88","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature09852","article-title":"Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis","volume":"471","author":"Oberst","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005756","article-title":"BRAF and AXL oncogenes drive RIPK3 expression loss in cancer","volume":"16","author":"Najafov","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib90","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","article-title":"Emerging connectivity of programmed cell death pathways and its physiological implications","volume":"21","author":"Bedoui","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib91","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","article-title":"Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors","volume":"94","author":"Luo","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib92","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","article-title":"Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis","volume":"94","author":"Li","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib93","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/cdd.2014.137","article-title":"Essential versus accessory aspects of cell death: recommendations of the NCCD 2015","volume":"22","author":"Galluzzi","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2025.12.005_bib94","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.cell.2020.03.040","article-title":"Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense","volume":"181","author":"Zheng","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib95","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41584-023-01002-7","article-title":"TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond","volume":"19","author":"Siegmund","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ccell.2025.12.005_bib96","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/15548627.2024.2319901","article-title":"International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis","volume":"20","author":"Chen","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.ccell.2025.12.005_bib97","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.ccell.2024.10.010","article-title":"Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib98","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.7150\/thno.89805","article-title":"Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer","volume":"14","author":"Zhu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ccell.2025.12.005_bib99","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","article-title":"Regulated cell death (RCD) in cancer: key pathways and targeted therapies","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ccell.2025.12.005_bib100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41580-018-0068-0","article-title":"Linking cellular stress responses to systemic homeostasis","volume":"19","author":"Galluzzi","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib101","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.molcel.2022.07.012","article-title":"Stressed to death: Mitochondrial stress responses connect respiration and apoptosis in cancer","volume":"82","author":"Winter","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib102","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tcb.2023.07.005","article-title":"Sublethal engagement of apoptotic pathways in residual cancer","volume":"34","author":"Killarney","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib103","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.devcel.2024.08.008","article-title":"Cell death: Revisiting the roads to ruin","volume":"59","author":"Green","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib104","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ccell.2025.03.002","article-title":"Horizontal mitochondrial transfer in cancer biology: Potential clinical relevance","volume":"43","author":"Berridge","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.cdd.4400594","article-title":"Caspase inhibitors","volume":"6","author":"Ekert","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2025.12.005_bib106","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41419-021-04240-3","article-title":"A long way to go: caspase inhibitors in clinical use","volume":"12","author":"Dhani","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ccell.2025.12.005_bib107","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.cell.2007.09.007","article-title":"Non-oncogene addiction and the stress phenotype of cancer cells","volume":"130","author":"Solimini","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib108","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41573-022-00415-5","article-title":"Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment","volume":"21","author":"Petroni","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib109","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","article-title":"bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death","volume":"74","author":"Boise","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib110","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.90.8.3516","article-title":"MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2","volume":"90","author":"Kozopas","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.12.005_bib111","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41418-025-01481-z","article-title":"The BCL-2 protein family: from discovery to drug development","volume":"32","author":"Croce","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2025.12.005_bib112","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib113","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.cdd.4402081","article-title":"Bcl-2 family proteins are essential for platelet survival","volume":"14","author":"Zhang","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2025.12.005_bib114","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41571-025-01068-0","article-title":"Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia","volume":"22","author":"Glaviano","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100885","article-title":"Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b\/2 study","volume":"6","author":"Davids","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.ccell.2025.12.005_bib116","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1158\/2159-8290.CD-22-1338","article-title":"BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance","volume":"13","author":"Zhao","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib117","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2159-8290.CD-19-0759","article-title":"Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade","volume":"11","author":"Kohlhapp","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib118","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib119","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer","volume":"11","author":"Fulda","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib120","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1245\/s10434-017-6109-7","article-title":"Isolated Limb Perfusion and Infusion for Extremity Soft Tissue Sarcoma: A Contemporary Systematic Review and Meta-Analysis","volume":"24","author":"Neuwirth","year":"2017","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib121","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41586-023-06367-z","article-title":"Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer","volume":"620","author":"Cassier","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib122","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.aad0395","article-title":"RIPK1 and NF-\u03baB signaling in dying cells determines cross-priming of CD8+ T cells","volume":"350","author":"Yatim","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.12.005_bib123","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.celrep.2016.03.037","article-title":"Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity","volume":"15","author":"Aaes","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.12.005_bib124","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1149673","article-title":"Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy","volume":"5","author":"Yang","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib125","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010433","article-title":"Defects in the necroptosis machinery are a cancer resistance mechanism to checkpoint inhibitor immunotherapy","volume":"13","author":"Sax","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12943-024-02172-y","article-title":"Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression","volume":"23","author":"He","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib127","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12943-025-02495-4","article-title":"Context-dependent impact of type I interferon signaling in cancer","volume":"24","author":"Ruiz-Iglesias","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib128","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","article-title":"Sublethal necroptosis signaling promotes inflammation and liver cancer","volume":"56","author":"Vucur","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.12.005_bib129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature17403","article-title":"The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression","volume":"532","author":"Seifert","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib130","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","article-title":"Decoding ferroptosis for cancer therapy","volume":"25","author":"Wahida","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib131","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib132","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","article-title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","volume":"24","author":"Russo","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib133","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","article-title":"Persister cancer cells: Iron addiction and vulnerability to ferroptosis","volume":"82","author":"Rodriguez","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib134","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3049","article-title":"Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer","volume":"15","author":"Li","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib135","article-title":"Lymph node environment drives FSP1 targetability in metastasizing melanoma","author":"Palma","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib136","article-title":"Targeting FSP1 triggers ferroptosis in lung cancer","author":"Wu","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib137","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-16-1979","article-title":"HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells","volume":"77","author":"Zhu","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.005_bib138","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib139","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","article-title":"Immunogenicity of ferroptosis in cancer: a matter of context?","volume":"10","author":"Catanzaro","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib141","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.12.005_bib142","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib143","article-title":"GPX4 released from ferroptotic cells acts on ZP3 receptors on dendritic cells to compromise cancer immunosurveillance","author":"Liu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib144","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","article-title":"Ferroptosis of tumour neutrophils causes immune suppression in cancer","volume":"612","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib145","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","article-title":"The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer","volume":"56","author":"Taifour","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.12.005_bib146","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.ccell.2025.12.005_bib147","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41419-021-03998-w","article-title":"Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines","volume":"12","author":"Zheng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ccell.2025.12.005_bib148","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological Functions of Autophagy Genes: A Disease Perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib149","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrclinonc.2011.71","article-title":"Autophagy as a target for anticancer therapy","volume":"8","author":"Janku","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib150","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib151","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3390\/curroncol29030141","article-title":"Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review","volume":"29","author":"Mohsen","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib152","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrd.2017.22","article-title":"Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles","volume":"16","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.11.012","article-title":"Targeting autophagy plus high-dose CDK4\/6 inhibitors in advanced HR+HER2- breast cancer: A phase 1b\/2 trial","volume":"6","author":"Gong","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.ccell.2025.12.005_bib154","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1038\/s41591-025-03877-3","article-title":"Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial","volume":"31","author":"DeMichele","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002722","article-title":"IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms","volume":"9","author":"Wu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib156","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41577-018-0095-2","article-title":"Autophagy in the renewal, differentiation and homeostasis of immune cells","volume":"19","author":"Clarke","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108105","article-title":"ENDOLUNG trial, part II. A phase II study of the Akt\/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel\/carboplatin in patients with squamous non-small cell lung cancer","volume":"201","author":"Bosch-Barrera","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib158","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","article-title":"Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance","volume":"37","author":"Marusyk","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003052","article-title":"The end of the genetic paradigm of cancer","volume":"23","author":"Huang","year":"2025","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib161","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM199705013361804","article-title":"High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma","volume":"336","author":"Gianni","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib162","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib163","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nrclinonc.2013.158","article-title":"Drug rechallenge and treatment beyond progression--implications for drug resistance","volume":"10","author":"Kuczynski","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib164","first-page":"209","article-title":"Conventional chemotherapy: millions of cures, unresolved therapeutic index","volume":"25","author":"Letai","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood.2023023154","article-title":"How I treat infant acute lymphoblastic leukemia","volume":"145","author":"Bartram","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.005_bib166","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2017-09-772640","article-title":"Optimizing therapy in advanced-stage Hodgkin lymphoma","volume":"131","author":"Lim","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.005_bib167","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2025.12.005_bib168","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib169","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.12.005_bib170","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib171","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.trecan.2024.02.008","article-title":"The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments","volume":"10","author":"Rayson","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib172","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib173","first-page":"187","article-title":"Immunosurveillance in clinical cancer management","volume":"74","author":"Kroemer","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ccell.2025.12.005_bib174","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ccell.2020.11.009","article-title":"Immunomodulation by targeted anticancer agents","volume":"39","author":"Petroni","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Timeline: Chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib176","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib177","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S1470-2045(24)00511-4","article-title":"Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis","volume":"25","author":"Mastrantoni","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib178","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-023-04017-6","article-title":"Immunogenic cell death in cancer: concept and therapeutic implications","volume":"21","author":"Galluzzi","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib179","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib180","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib181","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108130","article-title":"ATP and cancer immunosurveillance","volume":"40","author":"Kepp","year":"2021","journal-title":"Embo j"},{"key":"10.1016\/j.ccell.2025.12.005_bib182","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","article-title":"Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte","volume":"123","author":"Gardai","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib183","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-05912-0","article-title":"The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells","volume":"616","author":"Sen Santara","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib184","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2020.12.023","article-title":"Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance","volume":"39","author":"Lin","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib185","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.12.005_bib186","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib187","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1172\/JCI127471","article-title":"cGAS\/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2025.12.005_bib188","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41418-017-0017-z","article-title":"Autophagy induced during apoptosis degrades mitochondria and inhibits type I interferon secretion","volume":"25","author":"Lindqvist","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2025.12.005_bib189","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/imr.13272","article-title":"Type I interferon and cancer","volume":"321","author":"Holicek","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2025.12.005_bib190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fimmu.2015.00402","article-title":"Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer","volume":"6","author":"Fucikova","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib191","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.aad0779","article-title":"Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1","volume":"350","author":"Vacchelli","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.12.005_bib192","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib193","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib194","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2012.03.008","article-title":"F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells","volume":"36","author":"Ahrens","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.12.005_bib195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib196","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib197","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","article-title":"Drugging the efferocytosis process: concepts and opportunities","volume":"21","author":"Mehrotra","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.005_bib198","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","article-title":"The clearance of dead cells by efferocytosis","volume":"21","author":"Boada-Romero","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib199","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE(2) inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","article-title":"PGE(2) limits effector expansion of tumour-infiltrating stem-like CD8(+) T cells","volume":"629","author":"Lacher","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib201","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib202","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41590-021-00899-0","article-title":"Extracellular vesicles in immunomodulation and tumor progression","volume":"22","author":"Marar","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib203","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.005_bib204","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12943-024-02098-5","article-title":"Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance","volume":"23","author":"Montegut","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib206","article-title":"Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma","volume":"6","author":"Li","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib207","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41591-019-0566-4","article-title":"Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity","volume":"25","author":"Yang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib208","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.annonc.2022.05.010","article-title":"Impact of acetaminophen on the efficacy of immunotherapy in cancer patients","volume":"33","author":"Bessede","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib209","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cell.2019.01.016","article-title":"Acetylation Blocks cGAS Activity and Inhibits Self-DNA-Induced Autoimmunity","volume":"176","author":"Dai","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib210","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28518","article-title":"Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death","volume":"3","author":"Golden","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib211","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chembiol.2025.04.001","article-title":"Impact of radiation therapy on the immunological tumor microenvironment","volume":"32","author":"Guilbaud","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ccell.2025.12.005_bib212","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/emboj.2011.497","article-title":"A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death","volume":"31","author":"Garg","year":"2012","journal-title":"Embo j"},{"key":"10.1016\/j.ccell.2025.12.005_bib213","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.968434","article-title":"Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy","volume":"3","author":"Adkins","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib214","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41419-019-1819-3","article-title":"Extracorporeal photochemotherapy induces bona fide immunogenic cell death","volume":"10","author":"Tatsuno","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ccell.2025.12.005_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113721","article-title":"Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy","volume":"384","author":"Engelen","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ccell.2025.12.005_bib216","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41467-023-36045-7","article-title":"In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy","volume":"14","author":"Ou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.12.005_bib217","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2018.00085","article-title":"Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers","volume":"8","author":"Abdo","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib218","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ccell.2025.02.010","article-title":"Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.005_bib219","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/0008-5472.CAN-11-3185","article-title":"Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma","volume":"72","author":"Miyamoto","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.005_bib220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib221","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.47","article-title":"The oncolytic peptide LTX-315 triggers immunogenic cell death","volume":"7","author":"Zhou","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ccell.2025.12.005_bib222","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib223","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1606665","article-title":"A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers","volume":"8","author":"Kepp","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110727","article-title":"High-throughput screening system for immunogenic cell death inducers using artificial intelligence-based real-time image analysis","volume":"196","author":"Kim","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib225","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib226","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","article-title":"eIF2\u03b1 phosphorylation is pathognomonic for immunogenic cell death","volume":"25","author":"Bezu","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ccell.2025.12.005_bib227","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12943-024-02189-3","article-title":"AI-based classification of anticancer drugs reveals nucleolar condensation as a predictor of immunogenicity","volume":"23","author":"Cerrato","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib228","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911622","article-title":"Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress","volume":"12","author":"Humeau","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib229","doi-asserted-by":"crossref","first-page":"C128","DOI":"10.1158\/1535-7163.TARG-23-C128","article-title":"Abstract C128: PT-112, a novel immunogenic cell death inducer, causes ribosomal biogenesis inhibition and organelle stress in cancer cells","volume":"22","author":"Yim","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccell.2025.12.005_bib230","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1158\/1535-7163.MCT-21-0035","article-title":"Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In Vivo","volume":"20","author":"Montes de Oca","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccell.2025.12.005_bib231","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1038\/s41467-025-58266-8","article-title":"Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)","volume":"16","author":"Tsao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.12.005_bib232","doi-asserted-by":"crossref","first-page":"194","DOI":"10.15698\/cst2025.08.311","article-title":"Datopotamab deruxtecan induces hallmarks of immunogenic cell death","volume":"9","author":"Forveille","year":"2025","journal-title":"Cell Stress"},{"key":"10.1016\/j.ccell.2025.12.005_bib233","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010714","article-title":"Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade","volume":"13","author":"Zhao","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.12.005_bib234","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1656502","article-title":"Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity","volume":"8","author":"Xie","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib235","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2025.12.005_bib236","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1591875","article-title":"Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma","volume":"8","author":"Bommareddy","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib237","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib238","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41591-024-03414-8","article-title":"Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial","volume":"31","author":"Loi","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib239","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1200\/JCO.24.00358","article-title":"Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS)","volume":"43","author":"Martin-Broto","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib240","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1470-2045(22)00274-1","article-title":"Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial","volume":"23","author":"Antoniotti","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib241","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1721810","article-title":"PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models","volume":"9","author":"Yamazaki","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib242","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2093518","article-title":"PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer","volume":"11","author":"Liu","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib243","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/onc.2010.500","article-title":"Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress","volume":"30","author":"Martins","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2025.12.005_bib244","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025840118","article-title":"Activation of NF-kappaB and p300\/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation","volume":"118","author":"Zhou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.12.005_bib245","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41467-019-09415-3","article-title":"Crizotinib-induced immunogenic cell death in non-small cell lung cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.12.005_bib246","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1182\/blood.2023022777","article-title":"Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma","volume":"143","author":"Gulla","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.005_bib247","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1182\/blood-2006-10-054221","article-title":"Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications","volume":"109","author":"Spisek","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.005_bib248","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/intimm\/dxaf003","article-title":"Beneficial effects on T cells by photodynamic therapy with talaporfin enhance cancer immunotherapy","volume":"37","author":"Ezzaldeen","year":"2025","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib249","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2217\/fon-2018-0597","article-title":"ATLANTIS: a Phase III study of lurbinectedin\/doxorubicin versus topotecan or cyclophosphamide\/doxorubicin\/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line","volume":"15","author":"Farago","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib250","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(25)01011-6","article-title":"Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial","volume":"405","author":"Paz-Ares","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2025.12.005_bib251","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/1535-7163.MCT-23-0118","article-title":"Brentuximab Vedotin-Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity","volume":"23","author":"Heiser","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccell.2025.12.005_bib252","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-025-01212-0","article-title":"The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development","volume":"15","author":"Mukhopadhyay","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ccell.2025.12.005_bib253","doi-asserted-by":"crossref","first-page":"e801","DOI":"10.1016\/S2352-3026(23)00243-0","article-title":"Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study","volume":"10","author":"Dimopoulos","year":"2023","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.ccell.2025.12.005_bib254","article-title":"Belantamab Mafodotin Triggers Immune Invigoration in Multiple Myeloma Via Inflammatory and Immunogenic Cell Death","author":"Watson","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.ccell.2025.12.005_bib255","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1200\/JCO.22.02447","article-title":"US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer","volume":"41","author":"Narayan","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib256","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO-24-01349","article-title":"Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study","volume":"43","author":"Sands","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib257","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1038\/s41591-024-03267-1","article-title":"Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial","volume":"30","author":"Shatsky","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.12.005_bib258","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1158\/1078-0432.CCR-24-1513","article-title":"Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study","volume":"30","author":"Hamilton","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.005_bib259","article-title":"LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib260","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1962592","article-title":"LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells","volume":"10","author":"Yamazaki","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.005_bib261","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41419-025-07622-z","article-title":"Oncolytic peptide LTX-315 plus an anti-CTLA-4 antibody induces a synergistic anti-cancer immune response in residual tumors after radiofrequency ablation of hepatocellular carcinoma","volume":"16","author":"Sun","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ccell.2025.12.005_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2023.09.2190","article-title":"1051P Intratumoral injection of LTX-315 in combination with pembrolizumab in patients with advanced melanoma refractory to prior PD-1\/PD-L1 therapy: Interim results from the ATLAS-IT-05 trial","volume":"34","author":"Dalle","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2025.12.005_bib263","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ccell.2025.12.005_bib264","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/imr.13269","article-title":"Immunogenic cell death (ICD) enhancers-Drugs that enhance the perception of ICD by dendritic cells","volume":"321","author":"Liu","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2025.12.005_bib265","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825005392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825005392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:57:59Z","timestamp":1773961079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825005392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":265,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1535610825005392"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.12.005","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cell death: Cell-autonomous and immunogenic dimensions","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}